EDP Sciences logo
Web of Conferences logo
Search
Menu
All issues Volume 185 (2020) E3S Web Conf., 185 (2020) 03043 References
Open Access
Issue
E3S Web Conf.
Volume 185, 2020
2020 International Conference on Energy, Environment and Bioengineering (ICEEB 2020)
Article Number 03043
Number of page(s) 10
Section Medical Biology and Medical Signal Processing
DOI https://doi.org/10.1051/e3sconf/202018503043
Published online 01 September 2020
  1. Bretscher, A. J., Kodama-Namba, E., Busch, K. E., Murphy, R. J., Soltesz, Z., Laurent, P., & de Bono, M. (2011). [Google Scholar]
  2. Song, B. M., & Avery, L. (2013, January). The pharynx of the nematode C. elegans: a model system for the study of motor control. In Worm (Vol. 2, No. 1, pp. 1920–31). Taylor & Francis. [Google Scholar]
  3. Ann K. Corsi, B. W., and Martin Chalfie (2015). “A Transparent window into biology: A primer on Caenorhabditis elegans.” [Google Scholar]
  4. Riddle DL, B. T., Meyer BJ, et al. (1997). C. elegans [Google Scholar]
  5. Hobert, O. (2005). “Specification of the nervous system.” [Google Scholar]
  6. J.E. Sulston, E. S., J.G. White and J.N. Thomson (1983). “The Embryonic Cell Lineage of the Nematode Caenorhabditis elegans.”] [Google Scholar]
  7. Kerr, R. A. (2005). “Imaging the activity of neurons and muscles.” [Google Scholar]
  8. James J. Collins, C. H., Stacie Hughes, Kerry Kornfeld (2007). “The measurement and analysis of age-related changes in Caenorhabditis elegans.” [Google Scholar]
  9. Marton Lorant Toth, I. M., Leena Shah, Aatish Bhatia, Kevin Lu, Amish Talwar, Haaris Naji, Carolina Ibanez-Ventoso, Piya Ghose, Angela Jevince, Jian Xue, Laura A. Herndon, Gyan Bhanot, Chris Rongo, David H. Hall, and Monica Driscoll (2012). “Neurite Sprouting and Synapse Deterioration in the Aging Caenorhabditis elegans Nervous System.” [Google Scholar]
  10. Chiu-Ying Peng, C.-H. C., Jiun-Min Hsu, and Chun- Liang Pan (2011). “C. elegans model of neuronal aging.” [Google Scholar]
  11. Heehwa G. Son, O. A., Eun Ji E. Kim, Sujeong Kwon, and Seung‐Jae V. Lee (2019). “Age‐dependent changes and biomarkers of aging in Caenorhabditis elegans.” From https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413654/. [Google Scholar]
  12. Tavernarakis, V. N. a. N. (2012). “Calcium homeostasis in aging neurons.” [Google Scholar]
  13. M. Matthew Oh, F. A. O., Jack Waters and John F. Disterhoft (2013). “Altered Calcium Metabolism in Aging CA1 Hippocampal Pyramidal Neurons.” [Google Scholar]
  14. Javier Alvarez, P. A.-I., Paloma García-Casas, Rosalba I. Fonteriz, and Mayte Montero (2020). “The Role of Ca2+ Signaling in Aging and Neurodegeneration: Insights from Caenorhabditis elegans Models.” [Google Scholar]
  15. Chao., A. C. H. a. M. Y. (2010). Chapter 1From Odors to Behaviors in Caenorhabditis elegans. The Neurobiology of Olfaction. M. A. [Google Scholar]
  16. Koelle, M. (2005). Assessing defective or constitutive egg-laying. Wormbook. A. C. Hart. [Google Scholar]
  17. Zheng Liu, M. J. K., Christopher D. Chute, Amy K. Pribadi, Sarah G. Leinwand, Ada Tong, Kevin P. Curran, Neelanjan Bose, Frank C. Schroeder, Jagan Srinivasan & Sreekanth H. Chalasani (2018). “Predator-secreted sulfolipids induce defensive responses in C. elegans.” [Google Scholar]
  18. Laura Berliocchi, D. B., and Pierluigi Nicotera (2005). “Ca2+ signals and death programmes in neurons.” [Google Scholar]
  19. Heehwa G. Son, O. A., Eun Ji E. Kim, Sujeong Kwon, and Seung‐Jae V. Lee (2019). “Age‐dependent changes and biomarkers of aging in Caenorhabditis elegans.” [Google Scholar]
  20. David K Chow, C. F. G., Josiah L Johnston, Ilya G Goldberg, Catherine A Wolkow (2006). “Sarcopenia in the Caenorhabditis elegans pharynx correlates with muscle contraction rate over lifespan.” [Google Scholar]
  21. V.Lee, E. J. E. K.-J. (2019). “Recent progresses on anti-aging compounds and their targets in Caenorhabditis elegans.” [Google Scholar]
  22. Hyun Duk Yang, D. H. K., Sang Bong Lee, Linn Derg Young (2016). “History of Alzheimer’s Disease.” [Google Scholar]
  23. Pei-Pei Liu, Y. X., Xiao-Yan Meng & Jian-Sheng Kang (2019). “History and progress of hypotheses and clinical trials for Alzheimer’s disease.” [Google Scholar]
  24. George G. Glenner, C. W. W. (1984). “Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.”. [Google Scholar]
  25. Natalie S. Ryan, M. N. R., Nick C. Fox (2015). “Alzheimer’s disease in the 100 years since Alzheimer’s death.” [Google Scholar]
  26. Khalid Iqbal, F. L., Cheng-Xin Gong, and Inge Grundke-Iqbal (2011). “Tau in Alzheimer Disease and Related Tauopathies.” [Google Scholar]
  27. Corrada, C. H. K. a. M. M. (2012). “Alzheimer’s and Dementia in the Oldest-Old: A Century of Challenges.” [Google Scholar]
  28. Hélène-Marie Lanoiselée, G. N., 3 David Wallon, Anne Rovelet-Lecrux, Morgane Lacour, Stéphane Rousseau, Anne-Claire Richard, Florence Pasquier, Adeline Rollin-Sillaire, Olivier Martinaud, Muriel Quillard-Muraine, Vincent de la Sayette, Claire Boutoleau-Bretonniere, Frédérique Etcharry-Bouyx, Valérie Chauviré, Marie Sarazin, Isabelle le Ber, Stéphane Epelbaum, Thérèse Jonveaux, Olivier Rouaud, Mathieu Ceccaldi, Olivier Félician, Olivier Godefroy, Maite Formaglio, Bernard Croisile, Sophie Auriacombe, Ludivine Chamard, Jean-Louis Vincent, Mathilde Sauvée, Cecilia Marelli-Tosi, Audrey Gabelle, Canan Ozsancak, Jérémie Pariente, Claire Paquet, Didier Hannequin, Dominique Campion, and collaborators of the CNR-MAJ project (2017). “APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.” [Google Scholar]
  29. Genetic Alliance, The New York-Mid-Atlantic Consortium for Genetic and Newborn Screening Services(2009). Understanding Genetics: A New York, Mid-Atlantic Guide for Patients and Health Professionals. [Google Scholar]
  30. Chia-Chen Liu, T. K., Huaxi Xu, and Guojun Bu (2013). “Apolipoprotein E and Alzheimer disease: risk, mechanisms, and therapy.” [Google Scholar]
  31. Marcos Vinícius Ferreira Silva, C. d. M. G. L., Luan Carlos Vieira Alves, Leonardo Cruz de Souza, Karina Braga Gomes Borges & Maria das Graças Carvalho (2019). “Alzheimer’s disease: risk factors and potentially protective measures.” [Google Scholar]
  32. Pierrick Coupé, J. V. M., Enrique Lanuza, and Gwenaelle Catheline (2019). “Lifespan Changes of the Human Brain In Alzheimer’s Disease.” [Google Scholar]
  33. H Förstl, A. K. (1999). “Clinical features of Alzheimer’s disease.” [Google Scholar]
  34. W W Beatty, P. W., R L Adams, E W Allen, D A Wilson, J R Prince, K A Olson, K Dean, D Littleford (1994). “Preserved cognitive skills in dementia of the Alzheimer type.” [Google Scholar]
  35. Alfredo Damasceno, A. M. D., Daniel F C Mazo, João F D Zullo, Patricia Scherer, Ronny T Y Ng, Benito P Damasceno (2005). Primitive reflexes and cognitive function. Arq Neuropsiquiatr. [Google Scholar]
  36. Manabe, T., Fujikura, Y., Mizukami, K., Akatsu, H., & Kudo, K. (2019). Pneumonia-associated death in patients with dementia: A systematic review and meta-analysis. [Google Scholar]
  37. Jason Weller, a. A. B. (2018). “Current understanding of Alzheimer’s disease diagnosis and treatment.” [Google Scholar]
  38. Lawrence S. Honig, B. V., Michael Woodward, Mercè Boada, Roger Bullock, Michael Borrie, Klaus Hager, Niels Andreasen, Elio Scarpini, Hong Liu- Seifert, Michael Case, Robert A. Dean, (2018). “Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease.” [Google Scholar]
  39. Nygaard, H. B. (2017). “Targeting Fyn Kinase in Alzheimer’s Disease.” [Google Scholar]
  40. Jürgen Götz, A. I., and Lars M Ittner (2012). “Tau- targeted treatment strategies in Alzheimer’s disease.” [Google Scholar]
  41. Hoffman, M. (2020). “First Tau Imaging Agent for Alzheimer Disease FDA-Approved.” [Google Scholar]
  42. Masashi Kitazawa, R. M., and Frank M. LaFerla (2015). “Transgenic Mouse Models of Alzheimer Disease: Developing a Better Model as a Tool for Therapeutic Interventions.” [Google Scholar]
  43. Berridge, M. J. (2009). “Calcium hypothesis of Alzheimer’s disease.” [Google Scholar]
  44. Javier Alvarez, P. A.-I., Paloma García-Casas, Rosalba I. Fonteriz and and M. Montero (2020). “The Role of Ca2+ Signaling in Aging and Neurodegeneration: Insights from Caenorhabditis elegans Models.” [Google Scholar]
  45. Adanna G. Alexander, V. M. a. C. L. (2014). “Use of Caenorhabditis elegans as a model to study Alzheimer’s disease and other neurodegenerative diseases.” [Google Scholar]
  46. Can Zhang, A. B., Jason R. DiVito, Jesse A. Stevenson, Donna Romano, Yuanlin Dong, Zhongcong Xie, and Rudolph E. Tanzi (2012). “Amyloid-β Production Via Cleavage of Amyloid-β Protein Precursor is Modulated by Cell Density.” [Google Scholar]
  47. I Daigle, C. L. (1993). “apl-1, a Caenorhabditis elegans gene encoding a protein related to the human beta-amyloid protein precursor.” [Google Scholar]
  48. Angela Hornsten, J. L., Shruti Fadia, Richard Malins, Lawrence Ha, Xiaomeng Xu, Isabelle Daigle, Mindy Markowitz, Gregory O’Connor, Ronald Plasterk, and Chris Li (2007). “APL-1, a Caenorhabditis elegans protein related to the human β-amyloid precursor protein, is essential for viability.” [Google Scholar]
  49. Maya A. Koike, A. J. L., Jonathan Pham, Elaine Nguyen, James J. Yeh, Rombod Rahimian, Bruce J. Tromberg, Bernard Choi, Kim N. Green, Frank M. LaFerla (2012). “APP Knockout Mice Experience Acute Mortality as the Result of Ischemia.” [Google Scholar]
  50. Rasoul Godini, R. P., Hossein Fallahi (2019). “Caenorhabditis Elegans Hub Genes That Respond to Amyloid Beta Are Homologs of Genes Involved in Human Alzheimer’s Disease.” [Google Scholar]
  51. Jiang-Rong Ou, M.-S. T., An-Mu Xie, 3 Jin-Tai Yu, and Lan Tan (2014). “Heat Shock Protein 90 in Alzheimer’s Disease.” [Google Scholar]
  52. Dr Patricija van Oosten-Hawle, P. N. C. a. D. S. C. (2020). “An improved C. elegans model of Alzheimer’s disease to monitor neuronal signalling activity.” [Google Scholar]
  53. Tanzi, A. I. B. a. R. E. (2008). “Therapeutics for Alzheimer’s disease based on the metal hypothesis.” [Google Scholar]
  54. Yonggang Wang, X. M., Jian Sun, LuCai (2016). Chapter 6 - Oxidative Stress in Diabetes: Molecular Basis for Diet Supplementation. Molecular Nutrition and Diabetes. 55. Dagmar Pretsch, J. M. R., Axel Schmid, Miroslav Genov, Teresa Wöhrer, Liselotte Krenn, Mark Moloney, Ameya Kasture, Thomas Hummel & Alexander Pretsch (2020). “Prolongation of metallothionein induction combats Aß and α- synuclein toxicity in aged transgenic Caenorhabditis elegans.” [Google Scholar]
  55. Chun-Xue Yu, R.-Y. W. a., Feng-Ming Qi, Pan-Jie Su, Yi-Fan Yu, Bing Li, Ye Zhao, De-Juan Zhi, Zhan-Xin Zhang and Dong-Qing Fei (2020). “Eupulcherol A, a triterpenoid with a new carbon skeleton from Euphorbia pulcherrima, and its anti- Alzheimer’s disease bioactivity.” [Google Scholar]
  56. James A. Richardson, D. K. B. (2002). “Mouse Models of Alzheimer’s Disease: A Quest for Plaques.” [Google Scholar]
  57. Green, F. M. L. a. K. N. (2012). “Animal Models of Alzheimer Disease.” [Google Scholar]
  58. Masliah, C. A. L. a. E. (2010). “Can Alzheimer disease be prevented by amyloid-β immunotherapy?”. [Google Scholar]
  59. Claudia Saraceno, S. M., Elena Marcello, Silvia Pelucchi and Monica Di Luca (2013). “Modeling Alzheimer’s disease: from past to future.” [Google Scholar]
  60. Morgan Newman, E. E., and Michael Lardelli (2014). “Using the zebrafish model for Alzheimer’s disease research.” [Google Scholar]
  61. Ingrid H Philippens, P. R. O., Guus Baarends, Maja Johansson, Ed J Remarque, Magnus Doverskog (2017). “Acceleration of Amyloidosis by Inflammation in the Amyloid-Beta Marmoset Monkey Model of Alzheimer’s Disease. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.